Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Regulation of p73 by c-Abl through the p38 MAP kinase pathway

Abstract

p73 is a novel member of the p53 family of tumor suppressor proteins which is involved in cellular differentiation, tumor suppression, and the response to genotoxic stress. The molecular mechanisms regulating p73 activity are still poorly understood. Recently, p73 was found to be a target of the enzymatic activity of c-Abl, a non-receptor tyrosine kinase that potently activated in response to DNA damage. Here, we present evidence that c-Abl induces the phosphorylation of p73 in threonine residues adjacent to prolines, and that the p38 MAP kinase pathway mediates this response. Furthermore, we found that activation of p38 is sufficient to enhance the stability of p73, and that the transcriptional activation of p73 by c-Abl requires the activity of p38. These findings indicate that members of the MAP kinases superfamily of signaling molecules can regulate p73, and support a role for the p38 MAP kinase in a novel biochemical pathway by which c-Abl regulates this p53-related molecule.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Agami R, Blandino G, Oren M, Shaul Y . 1999 Nature 399: 809–813

  • Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, Fornace Jr AJ . 1999 EMBO J. 18: 6845–6854

  • Chandar N, Billig B, McMaster J, Novak J . 1992 Br. J. Cancer 65: 208–214

  • Chiariello M, Marinissen MJ, Gutkind JS . 2000 Mol. Cell. Biol. 20: 1747–1758

  • Cong F, Goff SP . 1999 Proc. Natl. Acad. Sci. USA 96: 13819–13824

  • Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM . 2000 Exp. Cell. Res. 256: 34–41

  • Fang L, Lee SW, Aaronson SA . 1999 J. Cell Biol. 147: 823–830

  • Fuchs SY, Adler V, Pincus MR, Ronai Z . 1998 Proc. Natl. Acad. Sci. USA 95: 10541–10546

  • Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M, Wang JY . 1999 Nature 399: 806–809

  • Gum RJ, McLaughlin MM, Kumar S, Wang Z, Bower MJ, Lee JC, Adams JL, Livi GP, Goldsmith EJ, Young PR . 1998 J. Biol. Chem. 273: 15605–15610

  • Han J, Lee JD, Jiang Y, Li Z, Feng L, Ulevitch RJ . 1996 J. Biol. Chem. 271: 2886–2891

  • Ip YT, Davis RJ . 1998 Curr. Opin. Cell. Biol. 10: 205–219

  • Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin WG . 2000 Nature 407: 645–648

  • Kaelin WG . 1999 Oncogene 18: 7701–7705

  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D . 1997 Cell 90: 809–819

  • Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW . 1991 Cancer Res. 51: 6304–6311

  • Kharbanda S, Pandey P, Ren R, Mayer B, Zon L, Kufe D . 1995a J. Biol. Chem. 270: 30278–30281

  • Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR, Kufe DW . 1995b Nature 376: 785–788

  • Kharbanda S, Yuan ZM, Weichselbaum R, Kufe D . 1998 Oncogene 17: 3309–3318

  • Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL . 2000 Immunopharmacology 47: 185–201

  • Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF . 2000 Nature 407: 642–645

  • Lohrum MA, Vousden KH . 1999 Cell Death Differ. 6: 1162–1168

  • Lohrum MA, Vousden KH . 2000 Trends Cell Biol. 10: 197–202

  • Mayer BJ, Baltimore D . 1994 Mol. Cell. Biol. 14: 2883–2894

  • Pandey P, Raingeaud J, Kaneki M, Weichselbaum R, Davis RJ, Kufe D, Kharbanda S . 1996 J. Biol. Chem. 271: 23775–23779

  • Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD . 2000 Science 289: 304–306

  • Sanchez-Prieto R, Rojas JM, Taya Y, Gutkind JS . 2000 Cancer Res. 60: 2464–2472

  • Steegenga WT, Shvarts A, Riteco N, Bos JL, Jochemsen AG . 1999 Mol. Cell. Biol. 19: 3885–3894

  • Vogelstein B, Kinzler KW . 1992 Cell 70: 523–526

  • Wang JY . 2000 Oncogene 19: 5643–5650

  • Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R, Kufe D . 1999 Nature 399: 814–817

  • Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Liu FF, Woodgett JR . 1996 Curr. Biol. 6: 606–613

Download references

Acknowledgements

We appreciate the comments of K Sakabe, C Murga, H Miyazaki, A Senderowicz, S Montaner, B Fletcher, V Patel and S Ramon y Cajal. We also appreciate the assistance and advice of L Vitale-Cross, C Parada and J Guinea.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Silvio Gutkind.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sanchez-Prieto, R., Sanchez-Arevalo, V., Servitja, JM. et al. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene 21, 974–979 (2002). https://doi.org/10.1038/sj.onc.1205134

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205134

Keywords

This article is cited by

Search

Quick links